Considering that GFAP levels were increased in cortical soluble fractions and presented decreased immunofluorescence, APT20TTMG appears to restore tissue homeostasis by normalizing mild astrogliosis, which is essential for regulating AD damage. This evidence concerns the gene GFAP and Alzheimer disease.